James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), bought 1,776 shares at $78.34 ($139K) on 2018-07-25, disclosed to the SEC on 2018-07-26.
Open-market purchase of $139k RETA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.34 | 888 | $70K | 50.0% |
| 2 | $78.34 | 888 | $70K | 50.0% |
| Total | $78.34 avg | 1,776 | $139K | 100% |
| Filing → |
| RETA | BUY | 2018-11-19 | $199K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |
| RETA | BUY | 2017-08-01 | $250K | — | Filing → |